Iovance Biotherapeutics Inc (IOVA)
Working Capital Ratio
39.04%
Quarterly · Period ending:
IOVA Working Capital Ratio
Latest reported39.04%period ending
Latest reported39.04%period ending
IOVA Quarterly Working Capital Ratio (85.03% → 39.04%)
Quarterly working capital ratio
High-resolution chart · PNG
IOVA working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 39.0384% | |
| 36.4151% | |
| 33.3269% | |
| 33.5164% | |
| 32.3268% | |
| 40.3372% | |
| 36.7605% | |
| 38.3933% | |
| 40.2996% | |
| 34.7561% | |
| 25.3145% | |
| 34.2163% | |
| 24.5922% | |
| 66.747% | |
| 58.3797% | |
| 53.238% | |
| 60.1431% | |
| 58.8795% | |
| 53.8709% | |
| 62.5295% | |
| 71.0733% | |
| 73.2985% | |
| 75.6358% | |
| 84.265% | |
| 89.014% | |
| 75.2125% | |
| 80.4889% | |
| 84.0676% | |
| 86.5064% | |
| 91.574% | |
| 95.8727% | |
| 92.008% | |
| 93.2741% | |
| 93.7471% | |
| 89.7183% | |
| 93.6058% | |
| 91.7123% | |
| 94.6592% | |
| 95.7286% | |
| 97.2779% | |
| 97.0043% | |
| 96.7857% | |
| 96.8709% | |
| 95.8226% | |
| 96.6086% | |
| 96.4426% | |
| 93.1336% | |
| 91.7049% | |
| 93.6756% | |
| 93.7834% | |
| 88.4385% | |
| -1,998.7446% | |
| -466.8105% | |
| -43,408.0472% | |
| -38,559.8681% | |
| -57,874.296% | |
| -25,391.4831% | |
| -22,513.8886% | |
| -2,256.2615% | |
| -169.5812% | |
| -331.2224% | |
| 1.846% | |
| 32.7217% | |
| 22.4332% | |
| 45.7973% | |
| 52.5226% | |
| -152.7512% | |
| -512.7574% | |
| -285.7484% | |
| -166.21% | |
| -4.8646% | |
| 69.3816% | |
| 75.167% | |
| 85.0261% |